Susceptible periods during embryogenesis of the heart and endocrine glands. by Sadler, T W
Susceptible Periods during Embryogenesis ofthe Heart and Endocrine Glands
T.W. Sadler
Department of Cell Biology and Anatomy, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
One of the original principles of teratology states that, "Susceptibility to teratogenesis varies with
the developmental stage at the time of exposure to an adverse influence" [Wilson JG. Environment
and Birth Defects. New York:Academic Press, 19731. The time of greatest sensitivity encompasses
the period of organ formation during weeks 3-8 following fertilization in human gestation. At this
time, stem cell populations for each organ's morphogenesis are established and inductive events
for the initiation of differentiation occur. Structural defects of the heart and endocrine system are no
exception to this axiom and have their origins during this time frame. Although the function and
maturation of these organs may be affected at later stages, structural defects and loss of cell types
usually occur during these early phases of development. Thus, to determine critical windows for
studying mechanisms of teratogenesis, it is essential to understand the developmental processes
that establish these organs. Key words: adrenal glands, embryology, heart, pancreas, parathyroid,
pituitary, thymus, thyroid. - Environ Health Perspect 108(suppl 3):555-561 (2000).
http.//ehpnetl.niehs.nih.gov/docs/2000/suppl-3/555-561sadler/abstract.html
Heart
The period of greatest risk for inducing
abnormal cardiac development occurs during
weeks 3-5 of gestation. Primary targets
include genes that regulate establishment of
the cardiogenic field and cardiac differentia-
tion, neural crest cells that contribute to par-
titioning ofthe aorticopulmonary channel,
and endocardial cushions. Heart cells origi-
nate near the primitive streak at approxi-
mately day 15 of gestation. Prospective
outflow tract cells lie most cranially in the
streak, followed by ventricular, then atrial
cells (1). These cells migrate through the
streak to the cardiogenic area cranial to the
cephalic neural folds. Here the cells lie in the
splanchnic mesoderm of the lateral plate,
adjacent to the underlying endoderm that
guides their migration along a fibronectin
rich path (Figure 1) (2). This endoderm is
also responsible for inducing cardiac progeni-
tor cells to form cardiac myocytes (3). Cells
in the cardiogenic region form a horseshoe-
shape tube with the open ends pointing cau-
dally (Figure 1). As lateral folding of the
embryo occurs, the two sides ofthe horseshoe
are brought together and fuse in the midline
to establish the heart tube (Figures 2, 3). By
day 23, the heart tube begins to bend to form
the cardiac loop (Figure 4). The outflow
region bends caudally and to the right, while
the atrial region moves dorsocranially and to
the left. Looping causes the heart to fold in
such a manner that the atria, ventricles, and
outflow tract assume their adult position but
remain unseptated (Figure 5).
Septation occurs from days 27-37 of
development with formation of the atrial,
ventricular, and conotruncal septa. In the
atria, this process depends upon downward
growth ofoverlapping septa from the roofof
the chamber to meet endocardial cushion
tissue surrounding the atrioventricular canal.
Prior to contact with cushion tissue, cell
death by apoptosis creates a hole in the first
septum to grow downward. The second sep-
tum grows over this opening but never
reaches the cushions to fuse. In this manner it
acts as a valve, such that blood flow from the
right atrium (receiving oxygenated blood
from the placenta) into the left is maintained.
At birth, when the lungs become functional
and oxygenated blood returns from these
organs into the left atrium, the valve will be
pressed closed to create an anatomically
complete interatrial septum.
Cushion tissue is also important for closing
the interventricular septum. Muscle tissue
from the expanding ventricles forms a column
oftissue comprising the ventral portion ofthe
interventricular septum. Endocardial cushion
tissue, derived from the region ofthe atrioven-
tricular canal, grows downward to join the
muscular column and completes the interven-
tricular septum, which then has muscular and
membranous portions. Most defects of this
septum occur in the membranous portion,
derived from cushion tissue (Figure 6).
The outflow tract or conotruncus is also
septated into the aortic and pulmonary chan-
nels by endocardial cushion tissue. Two
cushions growing from the sides ofthe cono-
truncus assume a spiral course and fuse in the
midline. Their spiral course is essential to
establish the appropriate connections for the
aortic and pulmonary trunks. As these cush-
ions grow downward, they meet and fuse with
cushion tissue surrounding the atrioventricular
canal, thereby completing the septation ofthis
region (Figure 6).
Finally, the superior and inferior endocar-
dial cushions surrounding the atrioventricular
canal grow together to separate this region
into two channels. Then, together with the
right and left cushions, they form the mitral
and tricuspidvalves (Figure 6).
It should be appreciated from the previous
discussion that endocardial cushions are a key
factor for normal heart development. Not sur-
prisingly, theyare also involved in the origin of
many cardiac defects, including atrial and ven-
tricular septal defects and abnormalities ofthe
conotruncal region, such as tetralogy ofFallot,
transposition ofthe great vessels, pulmonary
stenosis, and others. Thus, the cushions them-
selves are a potential target for teratogens and
merit further investigation. They are bounded
by the myocardium, which secretes a
hyaluronate-rich matrix (cardiac jelly) that
expands the space between the myocardial and
endothelial cells. At the time ofcushion differ-
entiation, the myocardium secretes EDTA-
soluble proteins that, in combination with
fibronectin, move through the matrixandtrans-
form some ofthe endothelial cells into mes-
enchyme (4). This epithelial-to-mesenchymal
transformation and delamination of these
endothelial cells require expression ofMSX-J;
influx of Ca; decreased expression of trans-
forming growth factor I (TGF-1); increased
expression ofsubstrate adhesion molecules,
including integrins; and an increase in uroki-
nase plasminogen activator (4-8). In short, a
complex orchestra ofmolecular and cellular
events that present targets for disruption is
essential for cushion differentiation and,
ultimately, heart morphogenesis.
The process ofcushion formation is further
complicated by the fact that neural crest cells
are essential for formation of the truncal
cushions that separate the distal portion of
the outflow tract into the pulmonary artery
and aorta (9). These crest cells, originating in
hindbrain rhombomeres 6,7, and 8, migrate
into pharyngeal arches 3, 4, and 6 and some,
the cardiac crest, continue into the outflow
tract where they augment the endothelial cells
in populating the truncal cushions. From the
hindbrain, these crest cells carry a specific
homeobox (HOX) code into the arches (10)
where they support development ofstructures
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derived from this region, including the aortic
arches, thymus, parathyroids, and thyroid.
Crest cells are particularly sensitive to toxic
insult from a variety of factors, including
alcohol and retinoids. They often respond by
undergoing apoptosis, in part because they
apparently lack antioxidative stress proteins
(11). Thus, they are a primary target to be
investigated and insults early in their forma-
tion, during the latter part ofweek 3, and
their migration, during the beginning ofweek
4, may result in combinations ofseemingly
unrelated birth defects. For example,
DiGeorge and velo-cardio-facial syndromes
may result from a deletion ofthe ql 1 region
ofchromosome 22 but can also be produced
by retinoids, alcohol, maternal diabetes, and
bis(dichloroacetyl)diamine, an inhibitor of
sperm production (12). Interestingly, abnor-
malities characteristic of these syndromes
include facial, heart, and glandular defects
involving the thymus, thyroid, and para-
thyroids. The target for these teratogenic
insults is crest cells from the hindbrain. Other
characteristic defects produced by insults to
cardiac crest include, tetralogy ofFallot, trans-
position ofthe great vessels, and persistent
truncus arteriosus.
In addition to crest and endothelial cells
that populate the endocardial cushions, cells in
the septum primum that undergo programmed
cell death during week 5 ofdevelopment are
potentially susceptible to toxicants. For exam-
ple, iftoo many ofthese cells undergo apopto-
sis, then atrial septal defects will occur.
Interestingly, in contrast to these septum pri-
mum cells, endothelial and myocardial cells
are resistant to cell-killing teratogens. Recent
evidence suggests that although these cells
express genes responsible for apoptosis, they
do not upregulate these genes following a
toxic insult, even when other tissues undergo
extensive cell death (13).
Genetic regulation ofheart development is
rapidly being elucidated, thereby providing
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Figure 1. (A) Drawing ofthe dorsal surface of a human embryo on day 18 postfertilization, illustrating the presence of angiogenic cell clusters in the cardiogenic region cranial to
the neural plate. These primordial cells have migrated through the primitive streak at the caudal end of the germ disc and now reside in the splanchnic mesoderm shown in cross
section in (B)and longitudinal section (C). (D) Scanning electron micrograph of a mouse embryo at a slightly later stage (approximately day 19, human; day7, mouse) showing coa-
lescence ofthe cardiac cells into a horseshoe shaped tube(arrows) lying in the pericardial cavity, beneath the head folds (asterisk) of the neural plate.
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Figure 2. (A-C) Drawings of cross sections through the cardiogenic region of 18-, 19-,
and 22-day (postfertilization) embryos. During this time, the embryo folds laterally in a
ventral direction, causing the two sides ofthe cardiac tube to come together and fuse in
the midline (C). By the time of fusion, myocytes form and the first cardiac contractions
are initiated. Simultaneously, the neural plate folds dorsally to form the neural tube and
neural crest cells from the hindbrain region (C) begin migrating to the cardiac outflow
tractto participate in partitioning this region into aortic and pulmonary channels.
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Figure 3. In addition to lateral folding from days 18-22 of gestation (Figure 2), the
embryo folds cranially and caudally. In the cranial region, this folding causes the heart
tube to move into the thoracic region.
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Figure 4. (A,B,C) Drawings illustrating various stages of cardiac looping on days
22-23. The primitive ventricular region grows downward and to the left, while the
atrial region moves cranially and to the right. These alterations are effected by
changes in cell shape and differential growth. (D,E) Scanning electron micrographs of
mouse embryos (day 8) showing the process of cardiac looping and expansion of the
ventricular region (V). The primitive atrium (A) moves upward, to the right, and poste-
riorly. The paired sinus venosus (S) represents the venous poles of the heart that lie
embedded in tissue forming the diaphragm (arrow).
A B
Leftventricle Interventricular
sulcus
Figure 5. (A,B) Drawings of the heart 24 days postfertilization illustrating how folding
has established the external appearance of four-chambered structure. Partitioning of
the heart into aortic and pulmonary channels has now begun. (C) Scanning electron
micrograph of a mouse heart (day 11) showing a stage similar to that in the drawings.
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Figure 6. (A) Drawing of a 35-day heart showing advanced stages of septation of the atrioventricular canal, ventricles, and outflow tract. Endocardial cushion tissue (swellings in
the outflow tract) is essential for partitioning of each ofthese regions and the atrial septum. Thus, many cardiac defects involve these cushions and affect these areas. In addition,
neural crest cells contribute to septation of the outflow tract in the truncus arteriosus, such that abnormalities in the migration, proliferation, or viability of these cells result in
defects, including transposition of the greatvessels, tetralogy of Fallot, and others. Since crest cells also contribute to formation of the face, many children with facial clefts also
have cardiac defects. (B) Scanning electron micrograph of a mouse heart (day 12.5) showing a stage similar to the drawing in A. Note the cushion (swellings) tissue in the outflow
tract and the ventricular septum.
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candidate genes to be investigated for potential
interactions with environmental influences.
As mentioned previously, neural crest cells
carry a HOXcode into the pharyngeal arches
and heart. These genes can be respecified by
retinoids and may also have their expressions
disrupted by other factors (14). Genes that
regulate establishment of the cardiogenic
field also contain a homeodomain and
belong to the NKfamily (15). NkX2-5 (also
known as CSX) is the homolog of the car-
diac-specifying gene tinman in Drosophila. In
vertebrates, NKX2-5specifies the cardiogenic
field and is also important for septation and
development of the conduction system.
Targeted disruption of this gene in mice
arrests cardiac development at the tube stage
prior to looping (16). In humans mutations
in this gene result in a variety ofheart abnor-
malities, including artial and ventricular sep-
tal defects and conduction irregularities (17).
TBX-5 contains a DNA-binding motif
known as a T-box and is also important for
septation. Mutations in this gene are respon-
sible for some cases ofHolt-Oram syndrome,
characterized by limb and heart abnormali-
ties, such as atrial and ventricular septal mal-
formations and conduction defects (18).
BMP-2 is expressed by the endoderm under-
lying the cardiogenic field and maintains
NKX2-5 expression, whereas Wnt genes
expressed in the cardiac region define the
limits ofthe field by restricting NKX2-5
expression (15). All these genes are expressed
early in week 3 ofdevelopment.
Adrenal Glands
The adrenal or suprarenal glands develop
from two sources: a) mesoderm (from the
urogenital ridge) that forms the cortex and
b) neurectoderm (neural crest cells) that
forms the medulla. Development is initiated
in week 5 postfertilization when epithelial
cells covering the cranial end ofthe urogenital
ridge near the root ofthe mesentery prolifer-
ate and penetrate the underlying mes-
enchyme. These cells form the fetal cortex,
which becomes verylarge. Shortly thereafter a
second wave ofcells from the epithelium pen-
etrates the mesenchyme, surrounds the first
cells, and forms the definitive cortex. These
cells will eventually differentiate into the zona
glomerulosa, zona fasciculata, and zona retic-
ularis, while the fetal cortex rapidly regresses
after birth. The significance ofits large size
and its function during the fetal period
is unknown.
As the fetal cortex is being formed during
week 5, neural crest cells from the 6th-12th
thoracic segments accompany the growth of
nerves from these same regions into the
gland. These cells form the medulla of the
gland and differentiate into chromaffin tissue.
Differentiation begins by week 12 and
continues until 12-18 months after birth.
Differentiation ofcortical zones begins 7-8
months after birth, but the adult structure of
this region is not attained until puberty.
Cortisol production during fetal development
is critical for lung maturation, deposition of
glycogen in the liver, and induction of
enzymes in the fetal brain, retina, pancreas,
andgastrointestinal tract (19).
Molecular regulation of adrenal gland
development has not been completely eluci-
dated. However, several genes have been
identified that play essential roles in initiation
and differentiation ofthe glands. For exam-
ple, recent evidence suggests that the Wilm's
tumor gene WTJ is critical for initiation of
cortex development (20). This gene is
expressed in body cavity epithelium and
underlying mesenchyme (21), suggesting that
it may play a role in epithelial-to-mesenchy-
mal transformations as these cells form the
adrenal cortex during the initiation ofgland
development (22).
Another gene important for early develop-
ment of adrenal tissue is steroidogenic
factor 1 (SF-1). Absence ofthis gene, which
belongs to the orphan nuclear receptor fam-
ily, results in agenesis ofthe adrenal glands
and gonads (22,23). In addition, SF-1 func-
tions as a transcription factor for a number of
steroidogenic enzyme genes (24-26), regu-
lates Miillerian-inhibiting substance promoter
(26), and modulates expression ofpituitary
gonadotrope cells (27-29). Interestingly,
SF-1 has been shown to interact with DAX-1,
the gene responsible for X-linked adrenal
hypoplasia congenita (30). These patients
lack an adrenal cortex and develop adrenal
insufficiency. DAX-1 is also a member ofthe
nuclear hormone receptor superfamily and
acts as a dominant negative regulator oftran-
scription mediated by the retinoic acid recep-
tor (30). It is a potent inhibitor of SF-1,
although how this interaction results in tissue
differentiation is unknown (31).
In addition to hypoplastic disorders ofthe
adrenal glands, a number of biochemical
abnormalities can result in congenital adrenal
hyperplasia (CAH). CAH is transmitted as an
autosomal recessive and is the leading cause
ofambiguous sexual abnormalites in the new-
born. Usually the defect results in an inability
to convert cholesterol to cortisol and/or
aldosterone and involves a deficiency in
21-hydroxylase activity, although defects in
other enzymes may result in similar outcomes.
21-Hydroxylase is responsible for converting
17-hydroxyprogesterone to 11-deoxycortisol
and progesterone to deoxycorticosterone. As a
result, adrenocortical-stimulating hormone
(ACTH) levels increase, which causes hyper-
plasia ofthe adrenal cortex and an increase in
steroid metabolites derived prior to the block
in the biochemical pathway.
Pancreas
In humans, the dorsal and ventral pancreatic
buds first appear 30 days after fertilization
(Figure 7), whereas genetic controls essential
for induction begin slightly before this time.
As with formation ofglands in general, pan-
creas development requires an epithelial-
mesenchymal interaction. In this case, the
mesenchyme induces the endoderm to prolif-
erate and to branch, perhaps under the influ-
ence offibroblast growth factors (32), and it is
this endoderm thatwill form both the exocrine
and endocrine cells of the organ (33).
Induction takes place in the caudal foregut in a
region of endoderm expressing PDXJ, a
homeodomain transcription factor required for
pancreas development. PDX1 is actually
expressed broadly in this region, but pancreatic
buds appearonly in an areawhere sonichedge-
hog expression in the endoderm is repressed
(34,35). Once growth is initiated, endoderm
cells differentiate into a, j, or 6 cells, produc-
ing glucagon, insulin, and somatostatin,
respectively, and exocrine cells. Follistatin, pro-
duced by mesenchyme cells, appears to regu-
late these differentiative processes by restricting
endocrine cell production and stimulating dif-
ferentiation ofexocrine cells (36). In addition,
PAX4is necessary for production of ,B and 8
cells (37), whereas PAX6is involved in a cell
differentiation (38). Similarly, the transcrip-
tion factor PTF1 is required for differentiation
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Figure 7. (A) Drawings showing initiation of dorsal and
ventral pancreatic buds at approximately 30 days post-
fertilization. Notethatthe buds appearfrom opposite sides
ofthe guttube and thatthe ventral bud arises from a com-
mon outgrowth thatwill form the liverand gall bladder. (B)
A slightly later stage in pancreas development showing
the ventral bud moving posteriorly to join the dorsal bud.
Endoderm from the gut tube forms the parenchyma of the
pancreas, gall bladder, and liver; whereas surrounding
mesoderm forms the connective tissue.
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and/or proliferation ofthe exocrine cells (39).
DefinitiveP cells appear in the pancreas by the
3rd month, although an initial wave may be
formed earlier during weeks 4-6 (36). These
earliest cells express insulin and glucagon but do
not associate to form islets. Insulin production
begins by the 5th month.
As the two buds increase in size, the
ventral bud moves into closer proximity to its
dorsal counterpart. By week 6, the two buds
fuse and the duct connecting the dorsal bud
to the foregut usually degenerates (Figure 8).
Malformations of the pancreas may be
most commonly related to inductive events.
For example, excessive growth of pancreatic
tissue, including annular pancreas, nesidio-
blastosis, and heterotopic pancreas, may all be
related to abnormal signaling during initial
phases of development (34,35). Whether or
not pancreatic function can be affected by
epigenetic factors acting on cell differentia-
tion is not clear. In any case, however, the
pancreas may have more than one window of
susceptibility: an early one during weeks 4-6
and a later one at weeks 10-12 when cells
are differentiating.
Thymus and Parathyroids
The thymus and parathyroids are also deriva-
tives of pharyngeal endoderm arising from
outpocketings of endoderm known as the
pharyngeal pouches (Figures 9, 10). Thus,
A
during week 5 ofgestation, the thymus and
superior parathyroid arise from proliferations
ofthe 3rd pharyngeal pouch and the superior
parathyroid from the 4th (Figure 10). While
the parathyroids assume a final position pos-
terior to the lobes of the thyroid, the thymic
anlagen migrate to the anterior mediastinum
where they fuse in the midline (Figure 11).
Induction and development of these
tissues again involve epithelial mesenchymal
interactions with much of the mesenchyme
derived from neural crest cells. As mentioned
previously, these cells are quite sensitive to
toxicants. Adverse effects on crest cells by
alcohol, retinoids, maternal diabetes, and
bis(dischloroacetyl)diamine results in
DiGeorge syndrome, which includes partial
or complete loss ofthe thymus, parathyroids,
and thyroid; craniofacial defects; and heart
abnormalities (12). The origin ofthe glandu-
lar defects is thought to be due to decreased
numbers ofcrest cells, leading to incomplete
formation ofthe pharyngeal arches, and dis-
ruption ofepithelial-mesenchymal signaling
essential for gland differentiation.
Thyroid
The thyroid gland develops from endoderm of
the floor ofthe pharynx at a point that later
demarcates the foramen cecum. The evagina-
tion appears during week 5 and this evagi-
nated tissue migrates caudally in the midline
to the level ofthe trachea as a bi-lobed struc-
ture (Figure 1 1). Differentiation occurs by
weeks 8-9 and thyroid hormone synthesis
begins by weeks 10-12. Thyroid hormones
are essential for brain development where they
a) promote neuronal and glial proliferation
and determine the time for terminating prolif-
eration and beginning differentiation; b) play
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Figure 8. Drawings of pancreas development at week 6
of development showing fusion of the dorsal and ventral
buds. The main duct is derived from the distal part of the
dorsal bud and the proximal part of the ventral. In 10%
of cases, the entire dorsal duct remains to form an
accessory pancreatic duct.
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Figure 9. Drawing of the exterior of a human embryo at
week 4 of gestation showing the presence of pharyngeal
arches. Mesenchyme from these arches contributes to
formation of the maxilla, mandible, and external ear.
Cartilage from each of the arches contributes to these
regions and the larynx. Internally, along the pharynx the
arches are lined by endoderm that will contribute to
glands in the head and neck. See Figures 10 and 11.
a role in neuronal migration by regulating
microtubule synthesis and assembly and con-
trolling the scaffolding for this cell movement;
c) enhance neuronal outgrowth by regulating
growth factors such as nerve growth factor;
d) stimulate development of dopaminergic
and cholinergic systems; and e) promote
myelination (40). These effects of thyroid
hormone on brain development occur in
three phases: phase I is regulated by maternal
sources of the hormone, extends from weeks
3-12, and encompasses the beginning stages
ofcerebral neurogenesis and migration; phase
II is regulated by fetal production ofthe hor-
mone from 12 weeks to birth and overlaps
many periods of neuronal proliferation,
migration, and differentiation throughout the
brain; phase III occurs during the postnatal
period as the central nervous system contin-
ues to differentiate (40).
This important action of thyroid
hormone on brain development and its
effects on growth make it a potential target
for environmental factors, but few studies
documenting such effects exist. Examples
include endemic iodine deficiency that causes
a decrease in thyroid hormone resulting in
many neurological deficits (41). Also there
is some evidence suggesting that dioxin
(2,3,7,8-tetrachlorodibenzo-p-dioxin) can
reduce thyroid hormone concentrations and
affect learning and memory capabilities (42).
Anterior Pituitary
The pituitary gland is derived from two
sources: the posterior lobe arises from neuroep-
ithelium ofthe diencephalon, the infundibu-
lum; the anterior and intermediate lobes from
an outpocketing ofepithelium in the oral cav-
ity (itselfa derivative of neural ectoderm from
the anterior neural ridge), called Rathke's
pouch (43) (Figure 12). Development begins
early in week 4 with inductive signals from the
diencephalon initiating formation ofRathke's
pouch. The homeobox gene TTF-] (NKX2-
1) is expressed in the diencephalon and is
essential for this inductive influence (44). By
week 8 ofdevelopment, the pouch pinches
offfrom the oral cavity and the cells undergo
rapid proliferation (43). As differentiation
continues, five cell types form in the anterior
pituitary: a) corticotropes, which produce
ACTH; b) thyrotropes, which synthesize
thyroid-stimulating hormone; c) soma-
trotropes, which produce growth hormone;
a) gonadotropes, which make lutenizing (LH)
and follicle-stimulating hormones (FSH); and
e) lactotropes, which secrete prolactin.
Corticotropes appear at approximately week 8
of development; thyrotropes on week 1 1;
somatotropes and lactotropes by week 11; and
gonadotropes for LH on week 12 and those
for FSH on week 13.
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Figure 10. Drawings of a longitudinal section through the pharyngeal region of a 4-week
embryo showing endoderm-lined pouches on the interior of the pharyngeal arches. These
pouches form the auditory tube (#1), palatine tonsils (#2), inferior parathyroid glands and
thymus (#3), and the superior parathyroid glands and ultimobranchial body (#4). Endoderm
from these regions forms the parenchyma of the glands and surrounding mesoderm forms
the connective tissue. These tissues migrate to their final positions, such that the thymus
drags the parathyroid tissue of the #3 pouch into a position inferior to that of similar tissue
from pouch #4. See Figure 11.
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Figure 11. Drawing of the pharyngeal region of a 6-week embryo showing continued
migration and development of the endocrine glands. Note that the thymus carries para-
thyroid tissue with it as it moves toward the superior mediastinum. The thyroid gland origi-
nates from endoderm in the floor of the pharynx and migrates in the midline to the larynx.
Remnants oftissues from any of these glands may remain along the path of migration.
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Figure 12. Drawings of sagittal sections through the region of the developing
pituitary gland. (A) Six-week embryo showing the dual origin of the gland: The
anterior lobe is derived from an outpocketing of oral epithelium called Rathke's
pouch; the posterior lobe represents a thickening of neural tissue in the floor of
the diencephalon called the infundibulum. (B,) Drawings of the pituitary region
showing further development in week 11 (B) and week 16().
Genetic regulation ofpituitary develop-
ment involves a cascade of genes and a nested
pattern ofhomeobox expression to create the
different cell types (45,46). PMXJ, a pituitary
homeobox gene, is the first to be expressed
throughout the epithelium ofthe stomadeum,
including Rathke's pouch, and appears to be
the upstream regulator ofpituitary differentia-
tion. Its expression is followed closely by that
of RPX(Rathke's pouch homeobox), whose
expression is transiently restricted to the
pouch from its initial stages ofmorphogenesis
until approximately the time ofcell differenti-
ation. RPX protein can heterodimerize with
the homeoprotein PROP 1 that upregulates
PIT], a POUfamily member essential for dif-
ferentiation ofthyrotrope, somatotrope, and
lactotrope cell lineage (47,48). Thus, RPX
appears to be a negative regulator ofpituitary
differentiation. In addition to these genes, the
transcription factors LIM3ILHX3 and
LIM4ILHX4 are required for pouch develop-
ment and subsequently proliferation and
differentiation ofspecific cell lineages (4$1(.
The sequential and restricted expression
of these genes is also essential for differentia-
tion of the various cell types. As mentioned,
P7XJ initiates the cascade in pituitary stem
cells. This expression upregulates expression
ofLIM3 and LIM4that are essential for con-
tinued pituitary development (50). Without
LIM3, pituitary morphogenesis is arrested at
the pouch stage. The combined expression of
PTX], RPX, and LIM3leads to the formation
ofgonadotropes. Expression of P7X], LIM3,
and PROP], together with downregulation of
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Table 1. Periods of susceptibility of the heart and
endocrine glands.
Sensitive periods
Tissue Early Late
Heart Weeks 3-6 ?
Adrenal
Cortex Weeks 5-8 7-8 months
Medulla Weeks 5-8 Week 12
Pancreas Weeks 4-8 Weeks 10-14
Thyroid Weeks 5-6 Weeks 8-9
Thymus Weeks 5-8 ?
Parathyroid Weeks 5-8 ?
Pituitary Weeks 4-9 Weeks 8-13
RPXresults in expression of PIT] (induced
by PROP]) and creation ofcells destined to
form thyrotropes, lactotropes, and soma-
totropes. To achieve final differentiation of
these specific cell types, additional genes have
to be expressed. Finally, expression of PIT]
and NeuroD] results in differentiation of
coticotropes (46).
Abnormalities in the expression pattern of
these genes has resulted in agenesis ofthe pitu-
itary(TTFJ, LIM3) (44,49) andgrowth inhibi-
tion (PIT], Snell dwarfmouse; PROP], Ames
dwarfmouse) (50-52). Whether environmen-
tal factors can impact this development is not
clear, but retinoids and other factors would
seem to be likely candidates to disrupt these
processes. One can imagine that the hypo-
thalmic-pituitary-endocrine axis is averysensi-
tive system with potentially small perturbations
capable ofhavingfar-reachingconsequences.
Summary
In summary, the heart and endocrine glands
have a high degree ofsensitivity duringweeks
3-8 of gestation when the anlage for these
organs and tissues is first established. In addi-
tion, later periods ofsensitivity may occur as
the various cell types begin to differentiate as
indicated in Table 1.
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